Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;

Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB et al. The Women’s Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004; 81(6):1498-1501.

Naftolin F, Schneider HPG, Sturdee DW, Birkhauser.M., Gambacciani M, Limpaphayom KK et al. Guidelines for hormone treatment of women in the menopausal transition and beyond. Climacteric 2004; 7(4):333-337

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection

George Alberti, Paul Zimmet and Jonathan Shaw. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Publication. Ed. Scott M. Grundy. Brussels, Belgium: International Diabetes Federation, 2006

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. Jama 2002; 287:356–359